FDA Sends Letter to Taro Over Ovide Promotion - Drugs.com MedNews
Links shared publicly online about this topic.
- 423total visits
FDA Sends Letter to Taro Over Ovide Promotion - Drugs.com MedNews
SILVER SPRING, Md., March 21, 2011 - The FDA today posted on its website a letter sent to Taro Pharmaceuticals regarding a book promoting its Ovide (malathion)
View full resource at drugs.com
Most Recently Shared on March 21, 2011 at 3:08 pm By:
FDA Sends Letter to Taro Over Ovide Promotion: SILVERÂ SPRING, Md., March 21, 2011 - The FDA today posted o... http://bit.ly/eXVWR7 #drug
Advertisement
